US
Europe (English)
Chinese
JapaneseAAV-ITR Sanger Sequencing
Azenta Life Sciences, formerly GENEWIZ’s new proprietary Sanger sequencing method sequences through difficult inverted terminal repeat (ITR) regions of adeno-associated virus (AAV), to expedite screening and validation of leads for your cell and gene therapy research.
This newly-developed protocol prevents abrupt reduction in the sequencing signal at the start of the ITR hairpin and reads through the full length of the ITR region. AAV-ITR sequencing can be combined with our Primer Walking service to sequence whole AAV vectors.
Azenta AAV-ITR Sequencing Provides a Breakthrough Solution
Adeno-associated virus (AAV) is one of the most actively investigated gene therapy vehicles. Azenta’s robust AAV-ITR Sequencing Protocol sequences through its difficult inverted terminal repeat (ITR) regions to better support your viral vector testing and drug discovery pipeline.
Standard Protocol
AAV-ITR Sequencing – GENEWIZ Proprietary Protocol
FEATURES & BENEFITS
AAV-ANCED STRATEGIES
For Adeno-Associated Virus in Gene Therapy
✓ Reliable quality control and safety testing for AAV development
✓ Strategies to read through inverted terminal repeats in AAV
✓ High-fidelity methods for AAV plasmid prep and packaging
✓ Advanced sequencing for AAV quality and safety monitoring
